Trial Details
RECRUITINGBasic Information
| Clinical ID | c904 |
|---|---|
| Identifier | NCT05058417 |
| Trial Title | Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Empagliflozin 10 MG|DRUG: Placebo |
Participant Information
| Sponsor | Sadat City University |
|---|---|
| City | Shibīn Al Kawm |
| Country/Region | Egypt |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2021-10-01 |
|---|---|
| Primary Completion Date | 2025-09-30 |
| Completion Date | 2025-12-31 |